Theravance Biopharma Inc. Ordinary Shares Forecast: Tomorrow, Week, Month, 5 Years

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Theravance Biopharma Inc. Ordinary Shares is projected near $16.50 versus the current reference around $16.62. That implies a modeled move of -0.71% over the next day, with realized prices still sensitive to intraday volatility.

The weekly Theravance Biopharma Inc. Ordinary Shares model points to $16.25, which maps to an expected drift of -2.20% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

The Theravance Biopharma Inc. Ordinary Shares 1-month target is $15.84 (-4.69%), while the 1-year target is $15.22 (-8.41%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

The Theravance Biopharma Inc. Ordinary Shares long-horizon scenario sits near $13.77 with a modeled change of -17.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

For Theravance Biopharma Inc. Ordinary Shares, nearest resistance is around $16.12, while nearest support is around $17.12. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.